Digital interventions to improve adherence to maintenance medication in asthma
Información
- DOI:
- https://doi.org/10.1002/14651858.CD013030Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 30 mayo 2018see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Vías respiratorias
- Copyright:
-
- Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Chan A: draft the protocol; develop and run search strategy; obtain copies of studies; select which studies to include; extract data from studies, enter data into RevMan; carry out and interpret analysis; draft final review; update review.
De Simoni A: draft the protocol; develop and run search strategy; obtain copies of studies; select which studies to include; extract data from studies; enter data into RevMan; carry out and interpret analysis; draft final review.
Wileman V: draft the protocol; develop and run search strategy; obtain copies of studies; select which studies to include; extract data from studies; enter data into RevMan; carry out and interpret analysis; draft final review.
Holliday L: draft the protocol; develop and run search strategy; obtain copies of studies; select which studies to include; extract data from studies; enter data into RevMan; carry out and interpret analysis; draft final review.
Chisari C: draft the protocol; develop and run search strategy; obtain copies of studies; select which studies to include; extract data from studies; enter data into RevMan; draft final review.
Newby C: draft the protocol; carry out and interpret analysis; draft final review.
Fleming L: review the protocol; review final review.
Taylor SJC: review the protocol; review final review.
Griffiths C: review the protocol; review final review.
Horne R: review the protocol; review final review; update review.
Sources of support
Internal sources
-
University College London, UK.
Authors AC, VW, CC, and RH are employed by the UCL and are completing this review whilst employed by this institution.
-
Queen Mary University, UK.
ADS, LH, CN, SJCT, and CG are researchers at the Centre for Primary Care and Public Health, Queen Mary University of London, and are completing this review whilst employed by this institution.
-
Royal Brompton Hospital, UK.
LF is employed by the Royal Brompton Hospital and is completing this review whilst employed at this institution.
External sources
-
Asthma UK Centre of Applied Research, UK.
Authors AC, ADS, CN, SJCT, LF, CG, and RH on this review are researchers affiliated with, and supported by, AUKCAR.
-
National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLARHC) North Thames at Bart's Health NHS Trust, UK.
RH, SJCT, and CG are supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart’s Health NHS Trust.
The views expressed are those of the review authors and are not necessarily those of the NHS, the NIHR, or the Department of Health.
-
No such funding has been specifically received for this review, Other.
Declarations of interest
Chan A: Amy Chan has received consultancy fees from Janssen‐Cilag, speaker fees from Novartis, and travel grants from Maurice Phyllis Paykel Trust and Max Health for activities outside this submitted work. Amy is also a freelance consultant for the UCL‐Business spin‐out Spoonful of Sugar Limited.
De Simoni A: none.
Wileman V: none.
Holliday L: none.
Chisari C: none.
Newby C: none.
Fleming L: consultancy fees from Vectura, advisory board fees from Boehringer Ingleheim and Novartis: paid to my Institution; personal speakers fees from Novartis and AstraZeneca.
Taylor SJC: none.
Griffiths C: none.
Horne R: personal fees from AbbVie, Amgen, Biogen, Idec, Gilead Sciences, GlaxoSmithKline; personal fees from Janssen, Pfizer, Roche, Shire Pharmaceuticals, MSD, Astellas, AstraZeneca, DRSU, Novartis, Universitatsklinikum Hamburg‐Eppendorf; cofounder of UCL‐Business spin‐out Spoonful of Sugar Limited.
Acknowledgements
The Background and Methods sections of this protocol are based on a standard template used by Cochrane Airways. The first background section of this protocol has been based on the published Cochrane review "Interventions to improve adherence to inhaled steroids for asthma" (Normansell 2017).
The authors of this work are affiliated with the Asthma UK Centre of Applied Research (AUKCAR), Queen Mary University of London, and University College London.
This project was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to Cochrane Airways. The views and opinions expressed therein are those of the review authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.
Version history
| Published | Title | Stage | Authors | Version |
| 2022 Jun 13 | Digital interventions to improve adherence to maintenance medication in asthma | Review | Amy Chan, Anna De Simoni, Vari Wileman, Lois Holliday, Chris J Newby, Claudia Chisari, Sana Ali, Natalee Zhu, Prathima Padakanti, Vasita Pinprachanan, Victoria Ting, Chris J Griffiths | |
| 2018 May 30 | Digital interventions to improve adherence to maintenance medication in asthma | Protocol | Amy HY Chan, Anna De Simoni, Vari Wileman, Lois Holliday, Claudia Chisari, Chris J Newby, Stephanie JC Taylor, Louise J Fleming, Chris J Griffiths, Rob Horne | |
